FHP
The computed 12-month bankruptcy probability of FHP is 0.2% (very low). The 2024 annual accounts show equity of €362k and a net result of €-396k. Equity is shrinking by ~74.7% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2025. Its solvency ranks better than 91% of 6573 sector peers (fiscal year 2024). The company has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals.
| Equity | €362k |
| Net result | €-396k |
| Better than sector | 91% |
| Active | 5 yrs |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Unlock the full score breakdown, per-year score history and the indicative credit limit with Plus.
See plans →How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 93.2% | 66.7% | |
| Net result | €-396k | €46k | |
| Equity | €362k | €79k | |
| Gross operating margin | €-396k | €78k | |
| Total assets | €388k | €154k |
| Fiscal year | 2024 |
|---|---|
| Deposit | micro |
| Revenue | - |
| EBITDA | - |
| Net profit | €-396k |
| Cash flow | - |
| Staff costs | - |
| Income taxes | - |
| Dividends | - |
| Total assets | €388k |
| Equity | €362k |
| Debt | €26k |
| of which ≤ 1y | €26k |
| of which > 1y | - |
| Working capital | €362k |
| Employees (FTE) | - |
| 2024 | |
|---|---|
| Current ratio | 14.78 |
| Quick ratio | 14.78 |
| Working capital ratio | 93.2% |
| Solvency | 93.2% |
| Debt / equity | 0.07 |
| Long-term debt ratio | - |
| Interest coverage | - |
| Gross margin | - |
| Net margin | - |
| ROA | -102.1% |
| ROE | -109.5% |
| EBITDA margin | - |
| Days sales outstanding | - |
| Days payable outstanding | - |
| Inventory turnover | - |
| Days inventory (DSI) | - |
| Line item | Code | 2024 |
|---|---|---|
| Balance sheet, Assets | ||
| TOTAL ASSETS | 20/58 | €388k |
| Current assets | 29/58 | €388k |
| Amounts receivable within one year | 40/41 | €14k |
| Cash & bank | 54/58 | €374k |
| Balance sheet, Equity & liabilities | ||
| TOTAL EQUITY & LIABILITIES | 10/49 | €388k |
| Equity | 10/15 | €362k |
| Contributions / capital | 10/11 | €3.10M |
| Accumulated profits (losses) | 14 | €-2.74M |
| Amounts payable | 17/49 | €26k |
| Amounts payable within one year | 42/48 | €26k |
| Trade debts payable within one year | 44 | €26k |
| Income statement | ||
| Gross operating margin | 9900 | €-396k |
| Operating result | 9901 | €-396k |
| Financial charges | 65 | €432 |
| Result before taxes | 9903 | €-396k |
| Net result for the period | 9904 | €-396k |
| Result to be appropriated | 9905 | €-396k |
-
HYLORIS PHARMACEUTICALSLegal entityDirector· perm. rep.: VAN ROMPAY StijnState Gazette act 26309715 (10-02-2026)Current10-02-2026 → present
-
Current05-02-2021 → present
-
Current05-02-2021 → present
-
Current05-02-2021 → present
-
Current05-02-2021 → present
Former directors (1)
-
Former- → 10-02-2026
| NACE primary | Human health(86910) |
| Legal form | Private limited company(610) |
| Incorporation | 29-01-2021 |
| Status | Active |
| Postal code | 2880 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 12038B0050/00C000 | Flanders | 2,329 m² | 1 · 336 m² | 11.7 m · 2 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
10-02-2026 1 director appointed, 1 resigning
- VAN ROMPAY Stijn, Bestuurder
- JACOBSEN Thomas, Bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "JACOBSEN Thomas",
"address": null,
"birth_date": null
},
"evidence_quote": "De vergadering besluit de Heer JACOBSEN Thomas, voornoemd, ontslag te geven uit zijn functie. De vergadering verleent volledige en algehele kwijting aan de ontslagnemende bestuurder voor de uitoefening van zijn mandaat.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "VAN ROMPAY Stijn",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "HYLORIS PHARMACEUTICALS",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "Wordt benoemd tot niet-statutaire bestuurder voor een onbepaalde duur: - De naamloze vennootschap \u201CHYLORIS PHARMACEUTICALS\u201D, voornoemd, met als vast vertegenwoordiger de Heer VAN ROMPAY Stijn, wonende te Keerbergen."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0762.693.578",
"name_full": "FHP",
"legal_form": "BV"
}
}11-02-2021 4 directors appointed
- Bart Peeters, Bestuurder
- Dominique Van Gucht, Bestuurder
- Ruth De Wulf, Bestuurder
- Thomas Gerner Jacobsen, Bestuurder
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Bart Peeters",
"address": null,
"birth_date": null
},
"effective_date": "2021-02-05",
"evidence_quote": "De algemene vergadering besluit de huidige bestuurders, hierna vermeld, overeenkomstig artikel 11 van de statuten als volgt aan te duiden: - De Heer Bart Peeters, wonend te 2880 Bornem, Scheldestraat 31 als A1 bestuurder;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Dominique Van Gucht",
"address": null,
"birth_date": null
},
"effective_date": "2021-02-05",
"evidence_quote": "De algemene vergadering besluit de huidige bestuurders, hierna vermeld, overeenkomstig artikel 11 van de statuten als volgt aan te duiden: - Mevrouw Dominique Van Gucht, wonend te 2880 Bornem, Scheldestraat 31 als A1 bestuurder;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ruth De Wulf",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0476260102",
"name": "Creafund NV",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2021-02-05",
"evidence_quote": "De algemene vergadering besluit de huidige bestuurders, hierna vermeld, overeenkomstig artikel 11 van de statuten als volgt aan te duiden: - Creafund NV, een naamloze vennootschap naar Belgisch recht, met zetel te Kapitein Maenhoutstraat 77/B, 9830 Sint-Martens-Latem en geregistreerd bij de Kruispun"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thomas Gerner Jacobsen",
"address": null,
"birth_date": null
},
"effective_date": "2021-02-05",
"evidence_quote": "De algemene vergadering besluit eveneens tot niet-statutaire bestuurder te benoemen voor een onbepaalde duur vanaf heden: - de Heer Thomas Gerner Jacobsen, wonend te 3000 Leuven, Naamsestraat 126, benoemd als B bestuurder."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0762.693.578",
"name_full": "FHP",
"legal_form": "BV"
}
}02-02-2021 Incorporation of a new BV
Technical details
{
"kind": "oprichting",
"seat": "2880 Bornem, Scheldestraat 31",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": "0759.736.563",
"name": "MAATSCHAP PURNA"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "A",
"partner_role": null,
"holder_org_kbo": "0759.736.563",
"holder_org_name": "MAATSCHAP PURNA",
"contribution_type": "cash",
"amount_paid_in_eur": 900,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 900,
"amount_subscribed_eur": 900,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1970-12-14",
"name": "PEETERS Bart Leo Maria Ghisele Machteld",
"niss": null,
"address": "2880 Bornem, Scheldestraat 31"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1050,
"holder_person_name": "PEETERS Bart Leo Maria Ghisele Machteld",
"is_subscriber_only": false,
"n_shares_subscribed": 1050,
"amount_subscribed_eur": 1050,
"is_anonymous_silent_partner": false
},
{
"org": null,
"kind": "natural_person",
"person": {
"dob": "1972-01-10",
"name": "VAN GUCHT Dominique Lea",
"niss": null,
"address": "2880 Bornem, Scheldestraat 31"
},
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": null,
"contribution_type": "cash",
"amount_paid_in_eur": 1050,
"holder_person_name": "VAN GUCHT Dominique Lea",
"is_subscriber_only": false,
"n_shares_subscribed": 1050,
"amount_subscribed_eur": 1050,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 3000,
"subject_company": {
"kbo": "0762.693.578",
"name_full": "FHP",
"legal_form": "BV"
},
"initial_directors": [],
"incorporation_date": "2021-01-28",
"post_incorporation_mandates": []
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | FHP |